Unknown PHASE2 INTERVENTIONAL 3-arm NCT05747508

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)

Sponsor: Bellerophon

Conditions Pulmonary Fibrosis Pulmonary Hypertension

Interventions INOpulse® Long Term Follow Up Placebo

Updated 4 times since 2023 Last updated: Feb 17, 2023 Started: Dec 29, 2017 Primary completion: Nov 22, 2019 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Pulmonary Fibrosis and Pulmonary Hypertension and is currently ongoing. Bellerophon leads this study, which shows 4 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Mar 2023 — Apr 2024 [monthly]

Active Not Recruiting PHASE2

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bellerophon

Data source: Bellerophon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Aurora, United States , Austell, United States , Chapel Hill, United States , Charleston, United States , Chesterfield, United States , Chicago, United States , Cincinnati, United States , Dallas, United States and 12 more locations